Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $751.1300 (-0.41%) ($751.1300 - $751.1300) on Wed. Feb. 15, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.69% (three month average) | RSI | 55 | Latest Price | $751.1300(-0.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 0.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(48%) XLV(43%) DIA(33%) VYM(30%) SPLV(29%) | Factors Impacting REGN price | REGN will decline at least -0.845% in a week (0% probabilities). VIXM(-13%) VXX(-8%) UUP(-4%) TBT(-4%) ACES(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.845% (StdDev 1.69%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $754.01(-0.38%) | 10 Day Moving Average | $759.9(-1.15%) | 20 Day Moving Average | $749.94(0.16%) | To recent high | -4.3% | To recent low | 10.4% | Market Cap | $79.641b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |